Activation of LL-A0341B biosynthesis: a cryptic cardiolipin targeting metabolite from Streptomyces formicae KY5
A mutant of Streptomyces formicae KY5 makes LL-A0341 A and B. Here, we identified the producing genes and targetted them to improve compound titres, allowing for detailed structural and bioactivity testing of this potent antimicrobial peptide.
Authors
- David Geoffrey Waterman (ORCID: https://orcid.org/0000-0002-2134-182X)
- Joseph A. Wright (ORCID: https://orcid.org/0000-0001-9603-1001)
- Barrie M. Wilkinson (ORCID: https://orcid.org/0000-0001-7646-7174)
- Julia E. A. Mundy (ORCID: https://orcid.org/0009-0006-6232-7254)
- Sergey A. Nepogodiev (ORCID: https://orcid.org/0000-0001-9796-4612)
- Gerhard Saalbach (ORCID: https://orcid.org/0000-0002-9849-4875)
- David M. Lawson (ORCID: https://orcid.org/0000-0002-7637-4303)
- Sandra Eltschkner (ORCID: https://orcid.org/0000-0002-9854-0800)
- Matthew I. Hutchings (ORCID: https://orcid.org/0000-0001-6628-5940)
- Claudio Greco (ORCID: https://orcid.org/0000-0003-3067-0999)
- Rebecca Devine (ORCID: https://orcid.org/0000-0003-0008-2184)
- Martin Rejzek (ORCID: https://orcid.org/0000-0002-5091-544X)
- Edward S. Hems (ORCID: https://orcid.org/0000-0002-5390-6020)
Institutions
- John Innes Centre (GB)
- University of East Anglia (GB)
- Rutherford Appleton Laboratory (GB)
- Norwich Research Park (GB)
- Swansea University (GB)
Publication Details
- Journal
- Chemical Science
- Published
- 2026-11-16
- DOI
- https://doi.org/10.1039/d6sc06987h
- Primary Topic
- Microbial Natural Products and Biosynthesis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Biotechnology and Biological Sciences Research Council